» Authors » Gaelle Fromont

Gaelle Fromont

Explore the profile of Gaelle Fromont including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 142
Citations 2094
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Le Mevel L, Bernhard J, Yacoub M, Waeckel T, Bazille C, Champy C, et al.
Clin Genitourin Cancer . 2025 Feb; 23(2):102305. PMID: 39999750
Objectives: To describe characteristics and survival outcomes of patients with renal collecting duct carcinoma (RCDC). Methods: We retrospectively analyzed data from patients treated for RCDC and included in the UroCCR...
2.
Ploussard G, Baboudjian M, Barret E, Brureau L, Fiard G, Fromont G, et al.
Fr J Urol . 2024 Nov; 34(12):102717. PMID: 39581668
Objective: The aim of the Oncology Committee of the French Urology Association is to propose updated recommendations for the diagnosis and management of localized prostate cancer (PCa). Methods: A systematic...
3.
Ploussard G, Dariane C, Mathieu R, Baboudjian M, Barret E, Brureau L, et al.
Fr J Urol . 2024 Nov; 34(12):102710. PMID: 39581665
Purpose Of This Document: The Oncology Committee of the French Urology Association is proposing updated recommendations for the management of recurrent and/or metastatic prostate cancer (PCa). Methods: A systematic review...
4.
Peyrottes A, Dariane C, Baboudjian M, Barret E, Brureau L, Fiard G, et al.
Eur Urol Oncol . 2024 Nov; PMID: 39562217
Background And Objective: The role of anatomical factors in predicting outcomes after radical prostatectomy (RP) remains unclear. This review aims to evaluate the impact of various anatomical factors on the...
5.
Mantha O, Mahe M, Maheo K, Fromont G, Gueguinou M, Tea I, et al.
Rapid Commun Mass Spectrom . 2024 Aug; 38(19):e9878. PMID: 39117991
Rationale: Natural variations in the abundance of the stable isotopes of nitrogen (δN) and carbon (δC) offer valuable insights into metabolic fluxes. In the wake of strong interest in cancer...
6.
Teyssonneau D, Dariane C, Barret E, Beauval J, Brureau L, Fiard G, et al.
Ther Adv Med Oncol . 2024 Jun; 16:17588359241242959. PMID: 38827177
Despite several improvements in outcomes, metastatic prostate cancer remains deadly. Alterations in the homologous recombination repair (HRR) pathway are associated with more aggressive disease. Olaparib and rucaparib, two poly-ADP-ribose polymerase...
7.
Baboudjian M, Peyrottes A, Dariane C, Fromont G, Denis J, Fiard G, et al.
Eur Urol Oncol . 2024 Jun; 7(6):1228-1245. PMID: 38824003
Background And Objective: Metastatic prostate cancer (mPCa) harbors genomic alterations that may predict targeted therapy efficacy. These alterations can be identified not only in tissue but also directly in biologic...
8.
Kervarrec T, Westphal D, Pissaloux D, Legrand M, Tirode F, Neuhart A, et al.
Histopathology . 2024 May; 85(4):566-578. PMID: 38785043
Aims: Porocarcinoma is a malignant sweat gland tumour differentiated toward the upper part of the sweat duct and may arise from the transformation of a preexisting benign poroma. In 2019,...
9.
Naffrichoux J, Poupin P, Pouillot W, Linassier C, Rioux-Leclercq N, De Vries-Brilland M, et al.
Eur J Cancer . 2024 May; 205:114121. PMID: 38749111
Introduction: Papillary renal cell carcinoma (pRCC) is a rare and aggressive cancer with no specifically established therapeutic strategy in the metastatic setting. Combinations of tyrosine kinase and immune checkpoint inhibitors...
10.
Papin M, Fontaine D, Goupille C, Figiel S, Domingo I, Pinault M, et al.
J Lipid Res . 2024 Apr; 65(5):100544. PMID: 38642894
SK3 channels are potassium channels found to promote tumor aggressiveness. We have previously demonstrated that SK3 is regulated by synthetic ether lipids, but the role of endogenous ether lipids is...